Welcome to our dedicated page for Maxlinear SEC filings (Ticker: MXL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
MaxLinear, Inc.'s SEC filings document its public-company disclosures as a semiconductor issuer focused on RF, analog, digital and mixed-signal integrated circuits. Recent 8-K filings cover quarterly operating results, material agreements, credit-facility amendments, share repurchase authorization and governance changes.
Proxy materials describe board structure, director elections, committee service, executive compensation, equity awards and shareholder voting matters. The filing record also reflects capital-structure items tied to common stock, revolving credit arrangements, subsidiary participation in financing agreements and the risk and governance disclosures associated with MaxLinear’s operating business.
MaxLinear insider Connie Kwong reported receipt of shares from RSU vesting and related withholdings. On 09/01/2025 Ms. Kwong received 58,909 shares of MaxLinear common stock as restricted stock units settled upon vesting. The filing also shows 58,152 shares were disposed of at a reported price of $15.72 (reflecting shares withheld to satisfy tax/withholding obligations). After the transactions, Ms. Kwong directly beneficially owns the delivered shares and retains 2,126 RSUs that remain subject to future vesting through August 20, 2026.
Steven G. Litchfield, Chief Financial Officer and Chief Corporate Strategy Officer of MaxLinear, Inc. (MXL), reported two dispositions on August 26, 2025. The filing shows sale of 100,880 shares at a weighted-average price of $17.2779 (range $17.16–$17.43) and an additional sale of 1,277 shares at $17.325. After these transactions the reporting person beneficially owned 312,203 shares (the filing lists 313,480 after the larger sale and 312,203 after the second sale). The report was signed by an attorney-in-fact on August 27, 2025.
MaxLinear, Inc. (MXL) filed a Form 144 notifying a proposed sale of 102,157 common shares through Morgan Stanley Smith Barney, with an aggregate market value of $1,765,108.49. The filing lists approximately 87,080,498 shares outstanding and an approximate sale date of 08/26/2025. The securities to be sold were acquired in three grants: 1,277 shares via an Employee Stock Purchase Plan on 05/17/2021, 47,725 restricted shares on 02/22/2019, and 53,155 performance shares on 02/17/2021. No sales by the seller were reported in the past three months. The signer certifies they have no undisclosed material adverse information about the issuer.
State Street Corporation reports beneficial ownership of 4,302,294 shares of MaxLinear Inc. common stock, representing 5% of the outstanding class. The filer discloses no sole voting or dispositive power; instead it reports shared voting power of 4,051,581 shares and shared dispositive power of 4,302,294 shares, indicating the position is managed collectively across accounts. The filing states the securities are held in the ordinary course of business and were not acquired to change or influence control. Several State Street advisory subsidiaries are named as the relevant holders, including SSGA Funds Management, State Street Global Advisors Europe Limited, State Street Global Advisors Limited and State Street Global Advisors Trust Company.
Form 4 — MaxLinear, Inc. (MXL): Steven G. Litchfield
The filing reports insider equity awards for Steven G. Litchfield (Chief Financial Officer and Chief Corporate Strategy Officer). On 07/27/2025 an outstanding option was amended: the "old" option (originally granted 08/10/2018, fully vested on 07/02/2022) was cancelled and a replacement option was granted. The replacement option covers 306,000 shares with an exercise price of $18.40, exercisable on 08/10/2025 and expiring 08/10/2028. Additionally, 77,760 Restricted Stock Units (RSUs) were granted on 08/04/2025, each representing one share, vesting one-third on 05/20/2026 and annually thereafter to full vesting on 05/20/2028. The form is signed by Connie Kwong as attorney-in-fact on 08/05/2025.